Andrew Cuthbertson, AO

BMedSci, MBBS, PhD, FTSE, FAHMS (Age 64)
Independent: No

Andrew Cuthbertson Chief Scientific Officer and R&D Director

Non-independent Executive Director

Director of CSL Limited since October 2018, and appointed Chief Scientific Officer and R&D Director in 2000.

Skills and experience
Professor Cuthbertson has over 35 years’ experience in medical research and biotech development with large biopharmaceutical companies and medical organisations.  He also has non-executive director experience.

Professor Cuthbertson joined CSL in April 1997 as the Director of Research. Prior to CSL, he was a Senior Scientist at Genentech Inc, a biotechnology company dedicated to pursuing ground-breaking science to discover and develop medicine for people with life-threatening diseases. After completing medical training at the University of Melbourne and PhD in Immunology at the Walter and Eliza Hall Institute in Australia, Professor Cuthbertson spent five years doing molecular biology research as a staff member at the Howard Florey Institute in Melbourne and the National Institutes of Health in the United States. In 2016, he was made an Officer of the Order of Australia and appointed Enterprise Professor at the University of Melbourne.

Other directorships and offices (current and recent):
  • Director of the Centre of Eye Research Australia (since March 2017)
  • Director of the Grattan Institute (since January 2019)
Innovation

Innovation spans across our organization with a focus on solving patients' unmet needs.

Learn More
Innovation

Innovation spans across our organization with a focus on solving patients' unmet needs.

Learn More
Recent News

Find out what's happening now at CSL.

Learn More

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter